US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

44.17

+1.252.91%

Post-market: 44.500.3280+0.74%18:25 EDT

Volume:3K

Turnover:135.58K

Market Cap:5.52M

PE:- -

High:44.21

Open:43.98

Low:43.98

Close:42.92

52wk High:45.10

52wk Low:25.71

Shares:125.00K

Float Shares:125.00K

Volume Ratio:1.84

T/O Rate:2.46%

Dividend:0.62

Dividend Rate:1.41%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Regeneron Says FDA Approves Pasatru for Adults with Rare Bone Disorder FOP

Regeneron Pharmaceuticals, - Pasatru Under Review by European Medicines Agency; Global Submissions Planned

THOMSON REUTERS

Regeneron Pharmaceuticals, - FDA Approves Pasatru (Garetosmab-Grts) for Adults with Fibrodysplasia Ossificans Progressiva

THOMSON REUTERS

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

MT Newswires Live

Why 2026 is Biotech's Comeback Year

Merck, Amgen Share Gains Contribute to Dow's 161-Point Climb

Femasys announces FDA approval of FemBloc modular premarket approval application

BetterLife Pharma Names Mahan Chehrenama Chief Medical Officer

Amgen Inc : Argus Research Raises Target Price to $460

THOMSON REUTERS

What This Top Biotech Fund is Buying Now

Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Disposes of USD 3.86 Million in Common Shares

TScan Therapeutics Faces Loss of Key Amgen Partnership

TScan Therapeutics - Amgen to Terminate Research Collaboration and License Agreement with TScan Therapeutics - SEC Filing

THOMSON REUTERS

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

Vortex Energy Finalizes 3D Tomography Study at Robinsons River Salt Project

Gilead Sciences Inc Stock (GILD) Moved Up by 3.14% on Aug 18: Drivers Behind the Movement

Argenx's Myositis Data Derisk Vyvgart Opportunity, Oppenheimer Says

MT Newswires Live

Argenx's Vyvgart Hytrulo Likely to Get FDA Approval for Myositis, RBC Says

MT Newswires Live

Argenx's Myositis Data Strengthen Efgartigimod Outlook, Morgan Stanley Says

MT Newswires Live

Amylyx Phase 3 data support FDA approval, says Citi

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/TBXU/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":44.172,"timestamp":1788292800000,"preClose":42.9245,"halted":0,"volume":3077,"hourTrading":{"tag":"盘后","latestPrice":44.5,"preClose":44.172,"latestTime":"18:25 EDT","volume":50,"amount":2215.7219999999998,"timestamp":1788301550400,"change":0.328,"changeRate":0.007426,"amplitude":0.007426},"delay":0,"changeRate":0.029062656524828364,"floatShares":125000,"shares":125000,"eps":0,"marketStatus":"Post-Mkt","change":1.2475,"latestTime":"09-01 19:01:47 EDT","open":43.98,"high":44.21,"low":43.98,"amount":135580.49711999999,"amplitude":0.005358,"askPrice":65.43,"askSize":200,"bidPrice":21.81,"bidSize":200,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788307200000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":42.9245,"sharesOutstanding":100001,"nav":42.586,"aum":5323310.01,"dividendRate":0.014077,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":44.5,"preClose":44.172,"latestTime":"18:25 EDT","volume":50,"amount":2215.7219999999998,"timestamp":1788301550400,"change":0.328,"changeRate":0.007426,"amplitude":0.007426},"volumeRatio":1.840531},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":125000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.840531,"shares":125000,"dividePrice":0.6218,"high":44.21,"amplitude":0.005358,"preClose":42.9245,"low":43.98,"week52Low":25.71,"pbRate":"--","week52High":45.1,"institutionHeld":0,"latestPrice":44.172,"eps":0,"divideRate":0.014077,"volume":3077,"delay":0,"ttmEps":0,"open":43.98,"prevYearClose":31.065,"prevWeekClose":42.5761,"prevMonthClose":42.9245,"prevQuarterClose":32.1223,"fiveDayClose":44.6232,"twentyDayClose":34.7187,"sixtyDayClose":30.5304},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660264427","title":"Regeneron Says FDA Approves Pasatru for Adults with Rare Bone Disorder FOP","url":"https://stock-news.laohu8.com/highlight/detail?id=2660264427","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660264427?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:02","pubTimestamp":1787162537,"startTime":"0","endTime":"0","summary":"Regeneron says FDA approves Pasatru for adults with rare bone disorder FOPRegeneron won FDA clearance for Pasatru (garetosmab-grts) to curb new HO lesions, clinician-assessed flare-ups in adults with ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDLKHCsC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU2362540622.SGD","LU0058720904.USD","LU2023250504.SGD","LU2468319806.SGD","LU0823434740.USD","LU0289739699.SGD","BK4139","LU0114720955.EUR","REGN","BK4588","TBXU","LU2106854487.HKD","IBBQ","LU1974910355.USD","LU2362541513.USD","LU0882574055.USD","LU0109394709.USD","IBB","BBH","LU2362541273.HKD","LU2237438978.USD","LU1917777945.USD","LU0823434583.USD","BK4585","LU0823416689.USD","LU0320765992.SGD","LU0889565916.HKD","LU0053666078.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660427109","title":"Regeneron Pharmaceuticals, - Pasatru Under Review by European Medicines Agency; Global Submissions Planned","url":"https://stock-news.laohu8.com/highlight/detail?id=2660427109","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660427109?lang=en_us&edition=fundamental","pubTime":"2026-08-20 01:58","pubTimestamp":1787162335,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nFWN44G1BJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","LU2089984988.USD","LU0882574055.USD","LU0114720955.EUR","LU0823434740.USD","BBH","LU2362541273.HKD","LU0053666078.USD","LU0889565916.HKD","IBB","LU2468319806.SGD","LU2106854487.HKD","BK4588","LU0289739699.SGD","LU2362541513.USD","BK4585","IBBQ","TBXU","LU0823416689.USD","LU0823434583.USD","LU0058720904.USD","REGN","LU2023250504.SGD","LU2237438978.USD","LU1974910355.USD","LU1917777945.USD","LU2362540622.SGD","LU0109394709.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660427103","title":"Regeneron Pharmaceuticals, - FDA Approves Pasatru (Garetosmab-Grts) for Adults with Fibrodysplasia Ossificans Progressiva","url":"https://stock-news.laohu8.com/highlight/detail?id=2660427103","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660427103?lang=en_us&edition=fundamental","pubTime":"2026-08-20 01:58","pubTimestamp":1787162335,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nFWN44G1BJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2237438978.USD","BK4139","LU1917777945.USD","LU1974910355.USD","IBB","LU0889565916.HKD","LU0289739699.SGD","LU0109394709.USD","LU2023250504.SGD","LU0114720955.EUR","LU2089984988.USD","LU0823434583.USD","TBXU","LU0058720904.USD","IBBQ","LU2362540622.SGD","LU2362541513.USD","BBH","LU2106854487.HKD","LU0320765992.SGD","REGN","LU2468319806.SGD","LU0823416689.USD","BK4585","LU2362541273.HKD","LU0823434740.USD","BK4588","LU0053666078.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660421716","title":"European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2660421716","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660421716?lang=en_us&edition=fundamental","pubTime":"2026-08-19 23:18","pubTimestamp":1787152727,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 0.68% to 1,973.64 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm BioNTech  and biopharmaceutical company Grifols , which advanced 24% and 5.6% respectively. They were followed by semiconductor company Sequans Communications  and biopharmaceutical company argenx , which rose 3.3% and 3% respectively.The decliners from continental Europe were led by internet browser company Opera  and biotech firm Evaxion , which fell 7.9% and 6% respectively. They were followed by accommodations booking site Trivago  and telecommunications company Nokia , which were down 4.3% and 1.6% respectively.The gainers from the UK were led by biotech firm Autolus Therapeutics  and mining company BHP Group , which increased 9.2% and 4.5% respectively. They were followed by software firm Endava  and biopharmaceutical company Bicycle Therapeutics , w","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AUTL","BK4588","LNOK","BNTX","IE00B4R5TH58.HKD","LU0006061336.USD","SLX","AFG","IE00B2B36J28.USD","IE0009355771.USD","BK4141","COAL","LU0300736062.USD","LU0109394709.USD","OPRA","TRVG","GRFS","BK4585","TRIB","LFGY","TBXU","DAVA.AU","BHP","LU0823416689.USD","LU0648005311.SGD","IE00BMPRXN33.USD","BDRX","LU2324357040.USD","NOK","SNN","DAVA","LU0889565916.HKD","EVAX","ARGX","EPV","BHP.AU","BK4117","FMED","BK4548","IEUR","IBB","LU1983260115.SGD","IE00BJT1NW94.SGD","NVIB","PUK","BK4547","SQNS","XBIX","IE00BJJMRZ35.SGD","BCYC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660421798","title":"Why 2026 is Biotech's Comeback Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2660421798","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660421798?lang=en_us&edition=fundamental","pubTime":"2026-08-19 23:16","pubTimestamp":1787152560,"startTime":"0","endTime":"0","summary":"This article was originally published on April 1, 2026. It has been updated to reflect recent developments.After a rough past few years, the biotech sector looks to be turning a corner. Major pharmace","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","LU0006306889.USD","WDNA","LU0198837287.USD","MRNY","LU0061475181.USD","LU0094547139.USD","SG9999017495.SGD","LU1551013342.USD","LU1145028129.USD","LU1267930730.SGD","LU1548497426.USD","IE00B775H168.HKD","LU2111349929.HKD","LLII","LU1989771016.USD","LU2456880835.USD","LU0672654240.SGD","BK4534","LU0820561909.HKD","LU2023251221.USD","LU0417517546.SGD","LU0466842654.USD","SGXZ31699556.SGD","LU0096364046.USD","IE0004445239.USD","SG9999014898.SGD","LU0225283273.USD","GB00BDT5M118.USD","SG9999014880.SGD","SG9999015978.USD","LU0823434583.USD","LU0943347566.SGD","LU0158827781.USD","LU2462157665.USD","LU2491050154.USD","MHIP","SG9999014914.USD","MEDI","SG9999018865.SGD","VHT","LU2236285917.USD","LU1366192091.USD","LU1093756325.SGD","LU2471134523.USD","LU0889565916.HKD","LU2237443382.USD","LU1868836914.USD","LU2491049909.HKD","IBBQ","LLY","PPH","BK4532","LGHT","LU2746668461.USD","IBB","LU2756315664.SGD","JDOC","LU2023250330.USD","LU2471134796.USD","LU2242646821.SGD","LU2237443895.HKD","LU2756315318.SGD","SG9999001176.SGD","LU2237443978.SGD","NVO","LU1551013425.SGD","MEDX","SG9999015945.SGD","LU1571399168.USD","LU0323591593.USD","LU2089283258.USD","LU0106261372.USD","IE00BJJMRX11.SGD","LU1974910355.USD","SGXZ81514606.USD","LU2213496289.HKD","LU2242652126.USD","LU2089284900.SGD","LU1979441026.SGD","IE00B4R5TH58.HKD","LU1623119135.USD","LU2552382058.USD","LU0683600562.USD","ELIS","LU1720051108.HKD","LU1057294990.SGD","LU1712237335.SGD","LU2168563687.JPY","LU0289739699.SGD","LU1023059063.AUD","LU0114720955.EUR","BK4548","LU0882574139.USD","BK4501","CURE","NVOX","LU1868836591.USD","LU2750360641.GBP","BK4585","BK4007","HRTS","LU0786609619.USD","LU2106854487.HKD","OZEM","LU2271345857.HKD","IE00BJLML261.HKD","LU0256863811.USD","LU0456855351.SGD","IE00BFTCPJ56.SGD","BK4533","LU1280957306.USD","IE00BKDWB100.SGD","LU2462591350.SGD","IDNA","LU1064131342.USD","LU1988902786.USD","LU2087625088.SGD","LU2168564065.EUR","LU2552382132.HKD","SG9999015986.USD","IE00BWXC8680.SGD","LU0320765992.SGD","GDOC","IE00BJJMRY28.SGD","LU0345770993.USD","LU2063271972.USD","LU0109391861.USD","LU0353189763.USD","IE00B4JS1V06.HKD","SGXZ99366536.SGD","LU0354030438.USD","PBE","LU2750360997.AUD","IE0004445015.USD","LU0345770308.USD","LU0820561818.USD","XLV","IE00BK4W5M84.HKD","LU0432979614.USD","IE00B7KXQ091.USD","BK4139","IHE","LU2237443622.USD","SG9999015952.SGD","LU2168564222.USD","LU2112291526.USD","LU2237443549.SGD","LU2552382215.SGD","LU0203201768.USD","LU2417539215.USD","ILDR","LU0385154629.USD","LU0079474960.USD","LU0174119429.USD","LU1691799644.USD","LU2896262040.SGD","NVOH","LU0689472784.USD","SG9999014906.USD","LU0154236417.USD","IE0001KFT4U8.USD","LU0133085943.USD","LU0820562030.AUD","LU1061106388.HKD","LU0256863902.USD","LU1983299246.USD","LU2265009873.SGD","LU0354030511.USD","LU2108987350.USD","TBXU","BK4581","LU0238689110.USD","ELIL","FHLC","LU0882574055.USD","LU0471298694.HKD","CANC","BK4566","LU0097036916.USD","LU1868837300.USD","TMED","BK4568","LU2602419157.SGD","LU0210536198.USD","LU2324357040.USD","AMGN","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU2023250504.SGD","LU2361045086.USD","TRUH","LU1720051017.SGD","LU2461242641.AUD","LU1232071149.USD","GNOM","LU1629891620.HKD","LU0353189680.USD","IE00BZ1G4Q59.USD","IE00BN29S564.USD","LU0823434740.USD","FTXH","BBH","LU2168564149.EUR","LU0640476718.USD","IE00B2B36J28.USD","SG9999001440.SGD","IYH","IE00BKPKM429.USD","BIB","IE0009355771.USD","BK4588","LU0122379950.USD","LU0787776722.HKD","MRNA","LLYZ","LU0471298777.SGD","LU1127390331.HKD","LU2089984988.USD","LU2471134952.CNY","BK4551","LU1323610961.USD","SG9999001176.USD","IE0002141913.USD","AGNG","LU0708995401.HKD","LU1868836757.USD","LU2211815571.USD","SGXZ57979304.SGD","04332","LU0109394709.USD","BK4599","LU0320765059.SGD","LU1814569148.SGD","IE0005OL40V9.USD","IE00B1XK9C88.USD","LU1069344957.HKD","LU2357305700.SGD","LU1804176565.USD","LU2746668974.SGD","IE00B1BXHZ80.USD","LLYX","SG9999018857.SGD","LU0158827948.USD","IE00BK4W5L77.USD","LU1868837136.USD","LU1917777945.USD","IE00BKVL7J92.USD","LU2491050071.SGD","LU0823416689.USD","LU2028103732.USD","LU0316494557.USD","LU2471134879.HKD","LU0058720904.USD","LU2468319806.SGD","SGXZ51526630.SGD","BK4516","LU1035775433.USD","LU0868494617.USD","RXL","LU1093756168.USD","LU2168564495.EUR","LU2361044865.SGD","LU0266013472.USD","LU0203202063.USD","LU2237443465.HKD","LU2360106947.USD","LU2264538146.SGD","IXJ","LU2237438978.USD","THNR","PJP","MRNX","LU1291159041.SGD","LU2361044949.HKD","LU0964807845.USD","IE00BFSS7M15.SGD","SG9999013999.USD","IE00BFSS8Q28.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660426691","title":"Merck, Amgen Share Gains Contribute to Dow's 161-Point Climb","url":"https://stock-news.laohu8.com/highlight/detail?id=2660426691","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660426691?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:45","pubTimestamp":1787147100,"startTime":"0","endTime":"0","summary":"DJ Merck, Amgen Share Gains Contribute To Dow's 161-Point ClimbThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Merck and Amgen are posting positive gains Wednesday morning, lifting the Dow Jones Industrial Average into positive territory.Shares of Merck  and Amgen  have contributed to the blue-chip gauge's intraday rally, as the Dow  was most recently trading 161 points higher .Merck's shares have climbed $12.37  while those of Amgen are up $13.30 , combining for an approximately 153-point bump for the Dow.Other components contributing significantly to the gain include Sherwin-Williams Co. , Home Depot , and Salesforce .A $1 move in any one of the 30 components of the benchmark results in a 5.94-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled August 19, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","IE000M9KFDE8.USD","DVY","LU0130102774.USD","LU1023059063.AUD","LU0477156953.USD","LU0130517989.USD","SG9999013999.USD","LU0868494617.USD","DOG","IE00BLSP4452.SGD","SGXZ57979304.SGD","BMED","LU1093756168.USD","LU0289739699.SGD","BK4533","LU2324357040.USD","BK4550","IBBQ","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0203345920.USD","SCHG","IE0009355771.USD","LU2491050071.SGD","MRK","IE00BBT3K403.USD","LU0689626769.HKD","LU1201861249.SGD","BK4534","LU1983299246.USD","IYH","IE00BJT1NW94.SGD","LU0432979614.USD","DGRW","LU0965509101.SGD","VHT","LU1941712348.USD","LU1066051225.USD","LU1989771016.USD","LU2360032135.SGD","MGK","LU1929549753.HKD","LU2112291526.USD","LU0109394709.USD","LU2125154778.USD","LU1093756325.SGD","LU0648001328.SGD","LU1037948897.HKD","BK4559","LU0889565916.HKD","LU1066051498.USD","IBB","IE0002141913.USD","PAWZ","BK4566","LU0006306889.USD","SG9999002232.USD","LU1061106388.HKD","SG9999014542.SGD","LU1699723380.USD","LU2461242641.AUD","IE00B2B36J28.USD","LU0320765489.SGD","LU1585245621.USD","LU0058720904.USD","LU1989772840.SGD","BK4516","LU1162221912.USD","LU2023250504.SGD","RXL","LU1934455277.USD","LU0942090050.USD","LU1116320901.HKD","LU0320765646.SGD","TBXU","LU0868494708.USD","IE00BLSP4239.USD","FDVV","MYMmain","GRNY","TRUH","IE00B1BXHZ80.USD","LU0070302665.USD","LU0124676726.USD","LU0823416689.USD","PJP","LU1035773651.USD","BIB","BBH","DJX","LU2468319806.SGD","VUG","VYMI","LU2357627491.SGD","SG9999001440.SGD","PPH","LU0965509010.AUD","SG9999014559.SGD","LU1116320737.USD","LU1430594728.SGD","SDY","LU0320765992.SGD","IXJ","LU1974910355.USD","LU2125154935.USD","DGRO","LU2106854487.HKD","LU0965509283.SGD","XLI","LU2125909247.SGD","HRTS","LU2361044865.SGD","LU0098860793.USD","LU2361044949.HKD","LU2125909593.SGD","LU2491050154.USD","SG9999001176.SGD","LU1057294990.SGD","LU0965508806.USD","LU0238689110.USD","SDOW","LU0980610538.SGD","SG9999014567.USD","FTXH","TOPT","LU2242652126.USD","LU1934455194.USD","LU0211331839.USD","LU0208291251.USD","LU2242646821.SGD","LU0122379950.USD","IE00BJJMRZ35.SGD","LU1066051811.HKD","BK4007","FDN","LU1066053197.SGD","SG9999001176.USD","LU0234572021.USD","DDM","LU2491049909.HKD","SG9999014575.USD","BK4599","DJIA","LU2023250843.SGD","FHLC","LU1941712264.USD","LU0859254822.USD","UDOW","LU0265550359.USD","BK4588","LU1923622614.USD","SG9999002224.SGD","LU0861579265.USD","LU0266013472.USD","04332","LU1934455863.HKD","BK4139","JDOC","GDOC","PBE","LU1917777945.USD","VYM","IE00BN8TJ469.HKD","SG9999015341.SGD","XLV","BK4581","LU1069347547.HKD","IE00BSNM7G36.USD","LU0203347892.USD","BK4585","DIA",".DJI","LU1989772923.USD","LU0265550946.USD","LU0985320562.USD","YMAX","IHE","AMGN","LU0106261372.USD","LU1291159041.SGD","DXD","LU2433249047.HKD","SCHD","SG9999015358.SGD","LU1037948541.HKD","LU2361045086.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660252964","title":"Femasys announces FDA approval of FemBloc modular premarket approval application","url":"https://stock-news.laohu8.com/highlight/detail?id=2660252964","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660252964?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:16","pubTimestamp":1787145413,"startTime":"0","endTime":"0","summary":"Femasys (FEMY) announced that the FDA has approved the company’s modular premarket approval application pathway for FemBloc, its investigational no...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/femasys-announces-fda-approval-of-fembloc-modular-premarket-approval-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/femasys-announces-fda-approval-of-fembloc-modular-premarket-approval-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","TECB","GNMX","PINK","GDOC","IBB","BK4584","FRTY","MRNX","IEIH","NVIB","BMED","BK4539","MRNY","BK4585","BK4588","IYH","BK4082","XLVX","BBP","LABU","IDNA","FEMY","MEDI","RSPH","SYNB","PSCH","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660142854","title":"BetterLife Pharma Names Mahan Chehrenama Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660142854","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660142854?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:04","pubTimestamp":1787141066,"startTime":"0","endTime":"0","summary":"BetterLife Pharma names Mahan Chehrenama chief medical officerBetterLife Pharma named Mahan Chehrenama as chief medical officer to lead clinical development of BETR-001.BETR-001 is advancing toward an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL40h7WP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242652126.USD","BK4588","IE0009355771.USD","PJP","PBE","BK4533","IBBQ","LU2242646821.SGD","BBH","BK4581","IE00BJT1NW94.SGD","BK4534","LU1983299246.USD","LU0122379950.USD","LU2112291526.USD","SG9999001440.SGD","LU0058720904.USD","LU0889565916.HKD","LU0289739699.SGD","TBXU","LU2089984988.USD","LU1061106388.HKD","BK4139","IE00BJJMRZ35.SGD","LU0109394709.USD","AMGN","IBB","LU2468319806.SGD","LU1057294990.SGD","BIB","LU0868494617.USD","IE00B2B36J28.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","BK4566","LU0320765992.SGD","LU1571399168.USD","BK4585","IE00B4R5TH58.HKD","LU1023059063.AUD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660344705","title":"Amgen Inc : Argus Research Raises Target Price to $460","url":"https://stock-news.laohu8.com/highlight/detail?id=2660344705","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660344705?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:25","pubTimestamp":1787138742,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nFWN44G0VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","LU2112291526.USD","LU0289739699.SGD","LU2468319806.SGD","PBE","BK4534","IE00BJT1NW94.SGD","BBH","LU1061106388.HKD","LU0058720904.USD","IE00BFTCPJ56.SGD","BK4139","IE0009355771.USD","BK4599","BIB","BK4581","IBB","LU2242646821.SGD","LU2089984988.USD","LU0868494617.USD","LU0109394709.USD","LU0889565916.HKD","LU1571399168.USD","LU1057294990.SGD","SG9999001440.SGD","LU1023059063.AUD","IE00B2B36J28.USD","TBXU","LU0122379950.USD","BK4566","IBBQ","PJP","IE0002141913.USD","LU2242652126.USD","IE00B4R5TH58.HKD","BK4588","IE00BJJMRZ35.SGD","BK4533","LU0320765992.SGD","LU1983299246.USD","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660417405","title":"What This Top Biotech Fund is Buying Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2660417405","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660417405?lang=en_us&edition=fundamental","pubTime":"2026-08-19 14:30","pubTimestamp":1787121000,"startTime":"0","endTime":"0","summary":"It's hard to find a more experienced biotech investor than Evan McCulloch. The manager of Franklin Biotechnology Discovery has been running the $1.2 billion fund since 1997.That matters in this highly","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","LU0053666078.USD","LU0395794307.EUR","PJP","LU2129689514.USD","IE00BKPKM429.USD","LU0689472784.USD","LU0553294199.USD","LU0070217475.USD","LU1121112475.USD","LU1043141396.HKD","LU2237443382.USD","LU0323591593.USD","LU0058720904.USD","LU2552382058.USD","LU2471134879.HKD","LU1720051108.HKD","SG9999015978.USD","LU0266013472.USD","AGNG","LU0061475181.USD","LU0466842654.USD","LU1989772840.SGD","LU0133085943.USD","LU0158827948.USD","IE000WAW04H5.SGD","LU2087625088.SGD","LU1988902786.USD","LU1093756168.USD","JAZZ","LU2133065610.SGD","IE00BN0W2W23.USD","LU0310800379.SGD","VHT","SGXZ80539844.SGD","SGXZ99366536.SGD","IE00B19Z9Z06.USD","LU0385154629.USD","LU2111349929.HKD","LU1221951046.USD","IE000BZT7R73.USD","LU1003077747.HKD","LU2089984988.USD","SG9999015952.SGD","LU2487616109.SGD","LU0820562030.AUD","LU1064131342.USD","LU2237443549.SGD","LU1066051498.USD","BK4599","LU0154245756.USD","LU2265009873.SGD","LU2237443622.USD","LU0289739343.SGD","IE00B3T34201.USD","LU0006306889.USD","SG9999014906.USD","PBE","LU0868494708.USD","LU2271345857.HKD","LU2125909593.SGD","IE00BGHQF631.EUR","LU1267930730.SGD","LU1291159041.SGD","LU0471298777.SGD","LU2213496289.HKD","LLYZ","LU0354030511.USD","IE00BN29S564.USD","LU2750360641.GBP","LU0345769631.USD","LU1674673428.USD","LU1814569148.SGD","LU1670628061.USD","LU0158827781.USD","LU0545562505.USD","LU0889565916.HKD","BK4532","SG9999015986.USD","IE00B1XK9C88.USD","LU0795875169.SGD","LU2106854487.HKD","LU0545039389.USD","LU0345770993.USD","LU2430703251.USD","BK4588","LU2461242641.AUD","LU0203347892.USD","IE00B894F039.SGD","LU1732799900.SGD","LU1037948897.HKD","LU0823416689.USD","LU1934455194.USD","LU1145028129.USD","IYH","JDOC","HRTS","LU1894683264.USD","IE00BK4W5M84.HKD","LU0122379950.USD","BBH","LU2237438978.USD","SG9999018865.SGD","LU0345769128.USD","LU2456880835.USD","LU1267930573.SGD","LU0256863811.USD","LU0097036916.USD","LU1032955483.USD","LU0109394709.USD","LU1267930813.SGD","LU1571399168.USD","LU0661504455.SGD","LU2756315664.SGD","LU2242652126.USD","BK4583","LU0426412945.USD","LU1868836914.USD","LU1023059063.AUD","LU0708995401.HKD","LU1069344957.HKD","LU2168563687.JPY","LU2505996509.AUD","IE00BFTCPJ56.SGD","LU1989772923.USD","LU0203202063.USD","LU1989771016.USD","BK4516","LU0726765562.USD","BK4567","IE0004445015.USD","IE00BN0W2T93.GBP","BK4534","LU0128525929.USD","LU1979441026.SGD","IE0005OL40V9.USD","IE00BVYPNV92.GBP","LU1718418525.SGD","LU0964807845.USD","CANC","LU0426417589.USD","LU0029864427.USD","VRTX","LU0792757196.USD","IE0001KFT4U8.USD","LU0234572021.USD","LU1261432733.SGD","LU2362541513.USD","BK4566","BK4139","WDNA","LU1732800096.USD","LU0640476718.USD","LU1868836591.USD","LU0472753341.HKD","LU1244550494.USD","LU0106261372.USD","LU0868494617.USD","LU2028103732.USD","LLY","IE00B4JS1V06.HKD","SG9999001176.SGD","TRUH","IE00BJJMRY28.SGD","IE00B19Z9P08.USD","LU2347655073.USD","LU0708994859.HKD","FHLC","IE00BJJMRX11.SGD","LU2471134523.USD","BK4578","LU0210536198.USD","LU2063271972.USD","IE0000B7K699.USD","ABBV","XBI","LU0098860793.USD","LU1934455277.USD","BK4504","LU2896262040.SGD","SG9999003800.SGD","LU0072461881.USD","BK4550","LU2168564495.EUR","LLYX","LU0965509101.SGD","LU1935042991.SGD","SGXZ51526630.SGD","IHE","LU2168564222.USD","LU1244550221.USD","LLII","LU2357627491.SGD","LU0889566641.SGD","LU2264538146.SGD","LU2491049909.HKD","LU2347655156.SGD","LU0154245673.USD","LU0310799852.SGD","LU1548497426.USD","IE00BJT1NW94.SGD","IE00B42XCP33.USD","LU0985320562.USD","LU1043141123.HKD","GILD","IE00BDGV0183.EUR","LU1934455863.HKD","SG9999002224.SGD","IE000MB6IJN5.SGD","LU1035775433.USD","MHIP","LU1923622614.USD","LU2362540622.SGD","LU1506573853.SGD","LU1914381329.SGD","IE00BKDWB100.SGD","LU2471134796.USD","LU0511384066.AUD","IXJ","LU0965508806.USD","LU0109391861.USD","LU1839511570.USD","IE00BLSP4239.USD","LU1228905037.USD","LU0096364046.USD","IE0004445239.USD","LU1430594728.SGD","SG9999014914.USD","MEDX","LU2746668461.USD","IE00BJJMRZ35.SGD","REGN","LU1868837136.USD","IE00BSNM7G36.USD","FTXH","IE00B19Z3581.USD","ELIS","IE00B7KXQ091.USD","IE000F7OJYX1.SGD","LU2552382215.SGD","LU2129689605.HKD","BK4585","LU0683600562.USD","IBBQ","LU2417539215.USD","IE00BN0W2V16.EUR","SGXZ57979304.SGD","LU0174119429.USD","IE00B7SZLL34.SGD","BK4592","LU0225283273.USD","SG9999017495.SGD","LU1037948541.HKD","LU2108987350.USD","IE000M9KFDE8.USD","LU2592432038.USD","IE0002141913.USD","LU1551013342.USD","SG9999002232.USD","LU2023250504.SGD","LU0882574139.USD","IE0034235303.USD","LU0354030438.USD","LU1778281490.HKD","LU1894683348.USD","LU2324357040.USD","04332","GNMX","JNJ","LU1585245621.USD","LU0203201768.USD","SG9999015945.SGD","IE00B1BXHZ80.USD","LU0320765059.SGD","LU1127390331.HKD","LU1974910355.USD","LU0114720955.EUR","LU1623119135.USD","LU0882574055.USD","LU1674673691.USD","LU1712237335.SGD","LU0069063385.USD","LU0198837287.USD","LU0211328371.USD","IE00BK4W5L77.USD","LU2129689431.USD","LU0256863902.USD","LU1366192091.USD","LU2430703178.SGD","BK4007","LU0320765646.SGD","LU0965509010.AUD","LU2089283258.USD","IE00BFSS7M15.SGD","LU1162221912.USD","LU1093756325.SGD","IE00B3PB1722.GBP","LU2211815571.USD","SG9999001176.USD","LU1983299246.USD","IE00BFXG1179.USD","LU0823434583.USD","LU2237443465.HKD","LU2361044949.HKD","XLV","LU1228905540.USD","LU0289961442.SGD","LU2361045086.USD","LU2357305700.SGD","LU0456855351.SGD","LU1496350171.SGD","OZEM","LU0820561818.USD","IE00BZ9MQY76.HKD","LU0238689110.USD","LU2505996681.GBP","LU0211327993.USD","LU0943347566.SGD","LU2433249047.HKD","LU1221951129.SGD","RXL","LU0057025933.USD","LU1929549753.HKD","LU0823434740.USD","SG9999018857.SGD","LU0353189680.USD","LU2491050154.USD","BK4559","IE0002270589.USD","IE00BWXC8680.SGD","LU2125909247.SGD","LU0320765992.SGD","LU0820561909.HKD","BK4568","LU0787776722.HKD","IE00BFSS8Q28.SGD","LU2112291526.USD","IE00BN8TJ469.HKD","BIB","LU0124676726.USD","LU0689626769.HKD","LU1804176565.USD","LU0417517546.SGD","LU2462591350.SGD","SGXZ31699556.SGD","LU1196500208.SGD","LU2471134952.CNY","IE00BLSP4452.SGD","LU0432979614.USD","LU0094547139.USD","BMED","LU1496350502.SGD","LU2236285917.USD","LU2361044865.SGD","LU0912757837.SGD","LU1061106388.HKD","SG9999001440.SGD","LU2237443895.HKD","IE00BVYPNW00.USD","LU2360106947.USD","GLAM","LU0942090050.USD","LU1074936037.SGD","LU2468319806.SGD","IE00BBT3K403.USD","IE00B775H168.HKD","LU2430703095.HKD","ELIL","LU1280957306.USD","SG9999013999.USD","LU1059921491.USD","IE00B4R5TH58.HKD","TBXU","THNR","XDNA","IE000SO60NU8.SGD","LU0234570918.USD","LU2087621335.USD","ILDR","LU2023251221.USD","IE00BZ1G4Q59.USD","LU1323610961.USD","GB00BDT5M118.USD","LU2242646821.SGD","LU1868837300.USD","LU2491050071.SGD","LU1057294990.SGD","LU0162691827.USD","LU2746668974.SGD","LU1629891620.HKD","SG9999014880.SGD","LU1232071149.USD","LU0994945656.USD","LU2403377893.USD","LU1720051017.SGD","IE00B2B36J28.USD","BK4581","LU2462157665.USD","LU0471298694.HKD","LU2750360997.AUD","LU1066053197.SGD","LU0949170772.SGD","LU2089284900.SGD","LU2756315318.SGD","LU0965509283.SGD","LU1244550577.SGD","SG9999011175.SGD","LU0861579265.USD","MEDI","BK4533","LU2023250330.USD","IE00B19Z3B42.SGD","LU0353189763.USD","SG9999014898.SGD","LU0672654240.SGD","LU0170899867.USD","LU2168564149.EUR","LU1066051225.USD","LU2602419157.SGD","TMED","LU0316494557.USD","IBB","LU1551013425.SGD","IE00BKVL7J92.USD","PPH","LU2168564065.EUR","LU0786609619.USD","IE00BJLML261.HKD","LU0210528500.USD","IE0009355771.USD","LU1267930490.SGD","LU2362541273.HKD","LU0345770308.USD","LU1066051811.HKD","LU2552382132.HKD","LU1868836757.USD","LU1917777945.USD","LU0738911758.USD","LU0289739699.SGD","IDNA","LU0859254822.USD","LU0795875086.SGD","AMGN","LU1670627923.USD","LU0203345920.USD","SGXZ81514606.USD","LU2237443978.SGD","LU1032466523.USD","CURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660490195","title":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Disposes of USD 3.86 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660490195","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660490195?lang=en_us&edition=fundamental","pubTime":"2026-08-19 06:54","pubTimestamp":1787093684,"startTime":"0","endTime":"0","summary":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier disposes of USD 3.86 million in common sharesGilead Chief Communications and Corporate Affairs Officer Johanna Mercier exercis","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLbJPzzx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Disposes of USD 3.86 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU0114720955.EUR","LU2468319806.SGD","MEDI","IE00B3T34201.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","LU1674673691.USD","BK4585","LU1674673428.USD","BIB","LU0965509283.SGD","SG9999015986.USD","TBXU","LU1066053197.SGD","LU1066051498.USD","BK4550","LU0861579265.USD","LU1585245621.USD","LU1037948541.HKD","BMED","LU1571399168.USD","IBB","BBH","IE00B19Z3581.USD","LU0889565916.HKD","LU2112291526.USD","LU0058720904.USD","BK4139","LU2087621335.USD","LU0823416689.USD","LU0122379950.USD","BK4588","GILD","TMED","LU1430594728.SGD","BK4566","IE00BZ1G4Q59.USD","LU1934455277.USD","LU2089984988.USD","IE00B7SZLL34.SGD","LU0234570918.USD","IBBQ","LU1057294990.SGD","LU2324357040.USD","LU0965509010.AUD","LU0289739699.SGD","BK4583","LU0965509101.SGD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660497970","title":"TScan Therapeutics Faces Loss of Key Amgen Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2660497970","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660497970?lang=en_us&edition=fundamental","pubTime":"2026-08-19 05:32","pubTimestamp":1787088742,"startTime":"0","endTime":"0","summary":"TScan Therapeutics ( ($TCRX) ) has shared an announcement. On August 12, 2026, TScan Therapeutics said that Amgen had exercised its right to termin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tscan-therapeutics-faces-loss-of-key-amgen-partnership?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tscan-therapeutics-faces-loss-of-key-amgen-partnership?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LENZ","AMGN","LU0889565916.HKD","IE0009355771.USD","BK4599","LU0109394709.USD","BIB","LU2242646821.SGD","IBB","TCRX","SG9999001440.SGD","BK4139","LU1983299246.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","LU1061106388.HKD","BK4566","BK4581","BK4533","LU0320765992.SGD","BK4539","IBBQ","IE00B2B36J28.USD","BK4585","BK4588","LU0289739699.SGD","LU2468319806.SGD","BK4534","LU0868494617.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU0122379950.USD","PBE","LU0058720904.USD","BBH","LU1571399168.USD","PJP","TBXU","LU2112291526.USD","IE00BJT1NW94.SGD","LU2089984988.USD","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492015","title":"TScan Therapeutics - Amgen to Terminate Research Collaboration and License Agreement with TScan Therapeutics - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492015","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492015?lang=en_us&edition=fundamental","pubTime":"2026-08-19 05:03","pubTimestamp":1787086998,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F15X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2468319806.SGD","IE00BJT1NW94.SGD","PBE","LU1571399168.USD","AMGN","BK4534","IE00BJJMRZ35.SGD","LU1057294990.SGD","BK4539","BIB","BK4533","TBXU","BK4566","IE00B4R5TH58.HKD","LU0058720904.USD","LU0289739699.SGD","LU1023059063.AUD","LU2089984988.USD","IE00BFTCPJ56.SGD","LU0868494617.USD","LU0320765992.SGD","LU1061106388.HKD","BK4585","LU2242652126.USD","TCRX","IBB","BBH","LU0122379950.USD","LU1983299246.USD","BK4139","IE00B2B36J28.USD","PJP","BK4581","LU0889565916.HKD","BK4599","LU2112291526.USD","BK4588","SG9999001440.SGD","IE0002141913.USD","LU2242646821.SGD","IE0009355771.USD","IBBQ","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492601","title":"Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492601","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492601?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:36","pubTimestamp":1787085360,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 3.25% to $143.44 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.69% to 7,691.76 and Dow Jones Industrial Average  falling 0.22% to 53,343.40.This was the stock's sixth consecutive day of gains.Gilead Sciences Inc. closed 8.81% below its 52-week high of $157.29, which the company reached on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  rose 3.33% to $271.11, Pfizer Inc.  rose 1.41% to $27.25, and Abbott Laboratories  rose 2.09% to $112.68.Trading volume  remained 1.9 million below its 50-day average volume of 7.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 18, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BMED","LU1585245621.USD","BK4578","LU0965509101.SGD","TBXU","LU1037948541.HKD","BBH","LU0109394709.USD","LU0889565916.HKD","LU1778281490.HKD","SG9999015952.SGD","LU1061106388.HKD","BK4568","LU1066053197.SGD","LU1037948897.HKD","IE00B19Z3B42.SGD","IBB","SG9999015986.USD","LU0114720955.EUR","IE00BKVL7J92.USD","LU1430594728.SGD","LU1839511570.USD","BK4550","IE00BSNM7G36.USD","IBBQ","BIB","BK4583","BK4588","IE0002270589.USD","LU0320765992.SGD","LU2087621335.USD","TMED","LU1934455194.USD","LU0965509283.SGD","LU2468319806.SGD","LU0234570918.USD","LU0823416689.USD","LU0289739699.SGD","MEDI","LU1934455863.HKD","LU0122379950.USD","IE00B3T34201.USD","BK4585","IE00B7SZLL34.SGD","LU1674673691.USD","LU2089984988.USD","LU0965509010.AUD","LU1674673428.USD","LU0058720904.USD","LU1934455277.USD","BK4139","GILD","LU2112291526.USD","BK4566","LU0861579265.USD","IE00BZ1G4Q59.USD","LU1023059063.AUD","LU0965508806.USD","SG9999015978.USD","LU1057294990.SGD","IE00B19Z3581.USD","LU1066051498.USD","LU1571399168.USD","SG9999015945.SGD","LU0882574055.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660912244","title":"Vortex Energy Finalizes 3D Tomography Study at Robinsons River Salt Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2660912244","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660912244?lang=en_us&edition=fundamental","pubTime":"2026-08-19 02:47","pubTimestamp":1787078856,"startTime":"0","endTime":"0","summary":"The latest update is out from Vortex Energy Corp. ( ($TSE:VRTX) ). Vortex Energy has released final results from an Ambient Noise Tomography survey...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-finalizes-3d-tomography-study-at-robinsons-river-salt-project?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-finalizes-3d-tomography-study-at-robinsons-river-salt-project?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0417517546.SGD","IE00B19Z3581.USD","PBE","GNMX","VRTX","IDNA","LU0061475181.USD","LU2362541513.USD","IBBQ","LU2362540622.SGD","SGXZ57979304.SGD","LU2324357040.USD","LU2417539215.USD","LU1093756325.SGD","LU2456880835.USD","LU1069344957.HKD","IE0002141913.USD","SG9999001176.USD","SG9999013999.USD","LU2362541273.HKD","TBXU","IE00B2B36J28.USD","BIB","LU0289739699.SGD","SG9999001176.SGD","IE00B894F039.SGD","LU0823416689.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","BK4585","LU0109394709.USD","LU1674673428.USD","LU1674673691.USD","IE00B4R5TH58.HKD","IE00B19Z9P08.USD","BBH","LU0234570918.USD","BK4588","LU1430594728.SGD","LU2462157665.USD","LU0889565916.HKD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU1093756168.USD","LU0256863811.USD","LU1035775433.USD","LU2236285917.USD","IBB","IE0009355771.USD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660491075","title":"Gilead Sciences Inc Stock (GILD) Moved Up by 3.14% on Aug 18: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2660491075","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660491075?lang=en_us&edition=fundamental","pubTime":"2026-08-19 02:15","pubTimestamp":1787076939,"startTime":"0","endTime":"0","summary":"• A federal court injunction blocks foreign importation of Gilead's key HIV medications.\n• Robust base-business revenue growth and raised guidance drove positive market sentiment.\n• Strategic oncology investments and bullish institutional options activity supported equity momentum.","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262115757-market-movers-gild-20260818","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LU0289739699.SGD","LU1057294990.SGD","IBB","LU1839511570.USD","BK4583","LU0114720955.EUR","SG9999015986.USD","TBXU","LU1571399168.USD","LU1934455194.USD","LU1430594728.SGD","TMED","LU1674673428.USD","BMED","LU0320765992.SGD","LU0889565916.HKD","SG9999015978.USD","LU0965509010.AUD","LU0965509101.SGD","BIB","LU1066051498.USD","LU2089984988.USD","IE00BSNM7G36.USD","BK4532","LU0882574055.USD","LU1934455863.HKD","LU1934455277.USD","LU0861579265.USD","IE00B19Z3B42.SGD","BBH","BK4566","LU0234570918.USD","BK4585","LU0122379950.USD","LU1037948541.HKD","LU2112291526.USD","LU0058720904.USD","IBBQ","BK4568","LU1061106388.HKD","MEDI","LU2087621335.USD","BK4139","IE0002270589.USD","IE00BKVL7J92.USD","LU0965509283.SGD","LU1023059063.AUD","IE00B7SZLL34.SGD","LU1037948897.HKD","BK4588","LU2324357040.USD","BK4550","LU0823416689.USD","GILD","LU1674673691.USD","LU0965508806.USD","LU1066053197.SGD","IE00B3T34201.USD","LU1585245621.USD","IE00BZ1G4Q59.USD","SG9999015952.SGD","LU0109394709.USD","IE00B19Z3581.USD","BK4578","LU1778281490.HKD","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660495742","title":"Argenx's Myositis Data Derisk Vyvgart Opportunity, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660495742","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660495742?lang=en_us&edition=fundamental","pubTime":"2026-08-18 23:35","pubTimestamp":1787067344,"startTime":"0","endTime":"0","summary":"Argenx's  phase 3 data on Vyvgart reduce the uncertainty around its potential $1.5 billion to $2 billion autoimmune myositis opportunity, Oppenheimer said.The phase 3 study of Vyvgart achieved its primary endpoint for the combined dermatomyositis and immune-mediated necrotizing myopathy, or IMNM, population, the investment firm said in a Monday note, noting IMNM as the therapy's \"most derisked\" path to approval.In the IMNM subgroup, Vyvgart-treated patients showed a 14.8-point greater improvement in mean Total Improvement Score versus placebo at week 52, a statistically significant result with a p-value of 0.0048, Oppenheimer added.The results are a testament to the company's pipeline-in-a-product strategy, bringing it closer to entering rheumatology as a second therapeutic category, according to the noteOppenheimer raised its price target on argenx to $1,100 from $1,037, while keeping its outperform outlook.Shares of Argenx were up 1.1% in Tuesday trading.Price: 998.83, Change: +10.99","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPY","IE00BJT1NW94.SGD","ARGX","IE00BJJMRZ35.SGD","BK4127","TBXU","FMED","LU1983260115.SGD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU2324357040.USD","BK4505","BK4585","IBB","BK4139","IE0034235188.USD","IE00B2B36J28.USD","LU0889565916.HKD","LU0823416689.USD","BK4588","IE0002141913.USD","IE0009355771.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660495503","title":"Argenx's Vyvgart Hytrulo Likely to Get FDA Approval for Myositis, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660495503","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660495503?lang=en_us&edition=fundamental","pubTime":"2026-08-18 23:06","pubTimestamp":1787065592,"startTime":"0","endTime":"0","summary":"Argenx's (ARGX) Vyvgart Hytrulo is likely to get approval from the US Food and Drug Administration for adults with immune-mediated necrotizing myopathy and dermatomyositis, RBC Capital Markets analyst","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1983260115.SGD","LU0823416689.USD","BK4505","LABU","IE00BJJMRZ35.SGD","LU0109394709.USD","FMED","BK4585","BK4588","IE00BJT1NW94.SGD","LU0320765992.SGD","IE0002141913.USD","IE0034235188.USD","LU0889565916.HKD","LU2324357040.USD","IE0009355771.USD","BK4139","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IBB","TBXU","ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660070493","title":"Argenx's Myositis Data Strengthen Efgartigimod Outlook, Morgan Stanley Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660070493","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660070493?lang=en_us&edition=fundamental","pubTime":"2026-08-18 22:54","pubTimestamp":1787064888,"startTime":"0","endTime":"0","summary":"Argenx's (ARGX) latest myositis data strengthened the outlook for efgartigimod, particularly in immune-mediated necrotizing myopathy, resulting in higher probability-of-success assumptions, Morgan Sta","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2324357040.USD","IE00BJJMRZ35.SGD","IBB","BK4585","IE0034235188.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","TBXU","BK4139","ARGX","BK4505","IE0002141913.USD","BK4588","LU0823416689.USD","FMED","BK4563","IE00B2B36J28.USD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU1983260115.SGD","LU0109394709.USD","IMNM","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660595493","title":"Amylyx Phase 3 data support FDA approval, says Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2660595493","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660595493?lang=en_us&edition=fundamental","pubTime":"2026-08-18 22:05","pubTimestamp":1787061936,"startTime":"0","endTime":"0","summary":"Citi says Amylyx’s (AMLX) avexitide showed a “highly differentiated” profile in the Phase 3 LUCIDITY study, a 78 participant, placebo-controlled tr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amylyx-phase-3-data-support-fda-approval-says-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amylyx-phase-3-data-support-fda-approval-says-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","BMED","MEDI","FRTY","PINK","TBXU","MRNX","BK4585","GNMX","LABU","MRNY","IDNA","IEIH","PSCH","BK4007","GDOC","XLVX","IYH","BBP","RSPH","BK4588","IBB","TECB","SYNB","AMLX","NVIB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}